Project Grant T32GM156572

The National Institute of General Medical Sciences (NIGMS) awarded a $103,158 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the Regents of the University of Minnesota, doing business as the Office of Sponsored Projects Administration. The grant will fund the Molecular Pharmacology and Therapeutics (MPAT) graduate program at the University of Minnesota over a 5-year period from July 2025 to June 2030.

The key objectives of this grant are to transform the MPAT program to better equip students with the skills needed to conduct impactful research and become leaders in the biomedical workforce. This will be achieved through updates to the curriculum, investments in recruitment and retention, enhanced career development activities, mentorship training, and continuous program evaluation. The grant will support 5 students per year for the first 2 years, with the goal of the MPAT program matriculating 12 incoming students annually and training approximately 60 students across all cohorts. The program aims to cultivate the next generation of pharmacologists to contribute to new therapeutic approaches for major health challenges.